PHF8 activators encompass a class of chemical compounds that target and modulate the activity of the Plant Homeodomain Finger Protein 8 (PHF8), a member of the family of Jumonji C-domain (JmjC) containing demethylases. PHF8 is an epigenetic enzyme that plays a pivotal role in chromatin remodeling and gene expression regulation by demethylating specific lysine residues on histone proteins, particularly histone H3 lysine 9 (H3K9me2) and histone H4 lysine 20 (H4K20me1). The removal of these methyl marks by PHF8 is associated with transcriptional activation, as it opens up the chromatin structure, allowing transcription machinery greater access to DNA.
The activation of PHF8 by chemical activators can occur through direct or indirect means. Direct activators may bind to the catalytic JmjC domain of PHF8, potentially increasing its enzymatic activity or altering its substrate specificity. They may enhance the binding of PHF8 to histone substrates or stabilize the enzyme in an active conformation. Indirect activators, on the other hand, may function by increasing the expression of PHF8, by modulating the cellular signaling pathways that control its activity, or by inhibiting the function of proteins that repress PHF8's demethylase activity. Research involving PHF8 activators is particularly interested in understanding how epigenetic modifications influence gene expression and the broader impact these modifications have on cellular processes such as differentiation, development, and the maintenance of genomic integrity. By employing PHF8 activators, scientists can investigate the consequences of altered histone demethylation on the expression of genes and the subsequent effects on cell phenotype.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor. By inhibiting HDACs, it maintains the acetylation state of histones, which favors an open chromatin structure and allows the binding and activity of PHF8. Thus, it indirectly enhances the activity of PHF8. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is another HDAC inhibitor. By maintaining histone acetylation, it promotes an open chromatin structure conducive to PHF8 binding and activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid is an HDAC inhibitor that maintains an acetylated state of histones, promoting an open chromatin state for PHF8 binding and activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
SAHA is an HDAC inhibitor that indirectly enhances PHF8 activity by maintaining an acetylated state of histones, promoting an open chromatin state where PHF8 can bind and function. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. By reducing DNA methylation, it can alter chromatin structure and indirectly enhance PHF8 activity. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $126.00 $278.00 $984.00 | 3 | |
Zebularine is a DNA methyltransferase inhibitor that reduces DNA methylation, altering the chromatin structure to favor PHF8 activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine is a DNA methyltransferase inhibitor. It reduces DNA methylation and modifies the chromatin structure, indirectly enhancing PHF8 activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor. By reducing DNA methylation, it changes the chromatin structure and indirectly enhances PHF8 activity. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $90.00 $238.00 $300.00 | ||
GSK126 is an EZH2 inhibitor. By reducing H3K27me3 levels, it indirectly enhances PHF8 activity. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 is an EZH2 inhibitor. It reduces H3K27me3 levels and indirectly enhances PHF8 activity. |